Global TMJ Disorders Market 2022-2028

August 2022 | 71 pages | ID: G2C9197524A3EN
Gen Consulting Company

Abstracts

According to latest analysis by Gen Consulting Company, the global tmj disorders market is poised to grow by USD 157 million during 2022-2028, progressing at a CAGR of 4.4% during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global tmj disorders market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the tmj disorders industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, treatment, end user, and region. The global market for tmj disorders can be segmented by type: arthritis, internal derangement, myofascial pain. Tmj disorders market is further segmented by treatment: medication, surgeries, therapies, others. Based on end user, the tmj disorders market is segmented into: academic and research institutes, ambulatory surgery centers (ASCs), hospitals & clinics, others. On the basis of region, the tmj disorders market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By type:

• arthritis
• internal derangement
• myofascial pain

By treatment:

• medication
• surgeries
• therapies
• others

By end user:

• academic and research institutes
• ambulatory surgery centers (ASCs)
• hospitals & clinics
• others

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The report has also analysed the competitive landscape of the global tmj disorders market with some of the key players being Abbott Laboratories, Allergan plc (AbbVie Inc.), Bayer AG, Jubilant Life Sciences Ltd., Mylan N.V., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., The Bristol-Myers Squibb Company, Zydus Lifesciences Limited, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global tmj disorders market.
• To classify and forecast the global tmj disorders market based on type, treatment, end user, region.
• To identify drivers and challenges for the global tmj disorders market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global tmj disorders market.
• To identify and analyze the profile of leading players operating in the global tmj disorders market.

Why Choose This Report

• Gain a reliable outlook of the global tmj disorders market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY TYPE

Arthritis
Internal derangement
Myofascial pain

PART 6. MARKET BREAKDOWN BY TREATMENT

Medication
Surgeries
Therapies
Others

PART 7. MARKET BREAKDOWN BY END USER

Academic and research institutes
Ambulatory surgery centers (ASCs)
Hospitals & clinics
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 9. KEY COMPANIES

Abbott Laboratories
Allergan plc (AbbVie Inc.)
Bayer AG
Jubilant Life Sciences Ltd.
Mylan N.V.
Novartis AG
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
The Bristol-Myers Squibb Company
Zydus Lifesciences Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER